Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2000-9-25
pubmed:abstractText
Cryptophycins are a family of antitubulin antitumor agents. A synthetic cryptophycin derivative (LY355703, CRYPTO 52) is in early clinical evaluation. The effect of infusion time on the antitumor activity of four cryptophycins was assessed in rats bearing the 13762 mammary carcinoma and combination treatment regimens were assessed in nude mice bearing human tumor xenografts.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0344-5704
pubmed:author
pubmed:issnType
Print
pubmed:volume
46
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
142-9
pubmed:dateRevised
2006-4-24
pubmed:meshHeading
pubmed-meshheading:10972484-Animals, pubmed-meshheading:10972484-Antibiotics, Antineoplastic, pubmed-meshheading:10972484-Antineoplastic Agents, pubmed-meshheading:10972484-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:10972484-Carcinoma, pubmed-meshheading:10972484-Depsipeptides, pubmed-meshheading:10972484-Female, pubmed-meshheading:10972484-Humans, pubmed-meshheading:10972484-Infusions, Intravenous, pubmed-meshheading:10972484-Lactams, pubmed-meshheading:10972484-Lactones, pubmed-meshheading:10972484-Lung Neoplasms, pubmed-meshheading:10972484-Male, pubmed-meshheading:10972484-Mammary Neoplasms, Experimental, pubmed-meshheading:10972484-Mice, pubmed-meshheading:10972484-Mice, Nude, pubmed-meshheading:10972484-Peptides, Cyclic, pubmed-meshheading:10972484-Rats, pubmed-meshheading:10972484-Rats, Inbred F344, pubmed-meshheading:10972484-Transplantation, Heterologous
pubmed:year
2000
pubmed:articleTitle
Antitumor activity of cryptophycins: effect of infusion time and combination studies.
pubmed:affiliation
Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285, USA.
pubmed:publicationType
Journal Article